Company profile
Recomgen Biotech company profile
Recomgen Biotech is an innovative biopharmaceutical company that focuses on large-scale serum-free continuous animal cell culture technology and the R&D of new biological drugs. Recomgen Biotech is working on developing rhTNK-tPA, a generation-specific thrombolytic drug that can be injected intravenously in a single dose, making it convenient for emergency treatment and out-of-hospital thrombolysis as needed. It improves the treatment rate, clinical benefit, and personal and societal medical burdens in patients with acute myocardial infarction who received thrombolytic therapy.
Business identity
- Website
- http://www.recomgenbio.com/
- Phone number
- 86-2082209991
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 251-500 employees
- Founded
- 2000-10-01
Headquarters
- Headquarters
- Guangzhou, Guangdong, China
- Country code
- CN
- Continent
- Asia